We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+17.33%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$961M
AUM Growth
+$374M
Cap. Flow
+$41.2M
Cap. Flow %
4.29%
Top 10 Hldgs %
44.93%
Holding
194
New
69
Increased
29
Reduced
39
Closed
48

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$24.6M
2
AGN
Allergan plc
AGN
+$24.2M
3
MRK icon
Merck
MRK
+$22.3M
4
AMGN icon
Amgen
AMGN
+$17.6M
5
ENDP
Endo International plc
ENDP
+$17.6M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$33.6M
2
SHPG
Shire pic
SHPG
+$20.7M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$18.2M
4
BIIB icon
Biogen
BIIB
+$11.8M
5
ISRL
Isramco Inc
ISRL
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 59.2%
2 Miscellaneous 33.43%
3 Technology 2.61%
4 Industrials 1.8%
5 Consumer Discretionary 1.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
176
DELISTED
Express Scripts Holding Company
ESRX
– –
-33,966
Closed -$2.88M
CASC
177
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-71,333
Closed -$813K
RXDX
178
DELISTED
Ignyta, Inc.
RXDX
– –
-179,055
Closed -$1.23M
CEMP
179
DELISTED
Cempra, Inc.
CEMP
– –
-100,000
Closed -$2.35M
CKP
180
DELISTED
CHECKPOINT SYSTEMS INC
CKP
– –
-19,688
Closed -$1.55M
ZSPH
181
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
– –
-20,682
Closed -$860K
LMNS
182
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$0 ﹤0.01%
+245
New +$2.66K
PCYC
183
DELISTED
PHARMACYCLICS INC
PCYC
– –
-48,840
Closed -$5.97M
SLXP
184
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-158,500
Closed -$18.2M
NPSP
185
DELISTED
NPS PHARMACEUTICALS INC
NPSP
– –
-80,000
Closed -$2.86M
CTIC
186
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-75,000
Closed -$1.77M
KBIO
187
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
– –
-43,695
Closed -$605K
ISRL
188
DELISTED
Isramco Inc
ISRL
– –
-80,733
Closed -$11.1M
LJPC
189
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-100,230
Closed -$1.85M
RPRX
190
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-100,000
Closed -$997K
GCVRZ
191
DELISTED
Sanofi Contingent Value Rights
GCVRZ
– –
-67,960
Closed -$6.22M
4 5 6 7
8

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q1 2015 Portfolio in Review

As of Q1 2015, Sphera Funds Management held 194 positions worth $961M, up 64% from $587M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sphera Funds Management deployed $41.2M of net new capital in Q1 2015, opening 69 new positions and adding to 29 existing holdings. Its largest new stake was AbbVie: 407,000 shares worth $23.8M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 69% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Novartis, an estimated $33.6M trimmed.

  • Sphera Funds Management's largest Q1 2015 buy was AbbVie: 407,000 shares worth $23.8M.
  • Sphera Funds Management added most to Allergan plc in Q1 2015, an estimated $24.2M increase.
  • Sphera Funds Management's biggest Q1 2015 reduction was Novartis, cutting an estimated $33.6M.
  • Sphera Funds Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q1 2015, selling an estimated $18.2M.
  • Sphera Funds Management's ten largest holdings make up 45% of its $961M portfolio in Q1 2015.
  • Sphera Funds Management opened 69 new positions and closed 48 in Q1 2015.
  • Sphera Funds Management's portfolio value rose 64% quarter-over-quarter to $961M.

Based on Sphera Funds Management's 13F filing for Q1 2015, filed 11 May 2015.